Lewes, DE -- (SBWire) -- 10/09/2018 --Injectable Anticoagulants Market will register a 2.7% CAGR in terms of revenue, reach US$ 6440 million by 2023, from US$ 5490 million in 2017.
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).
In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.
The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in 2016 is about 55%, and the proportion is in decreasing trend from 2012 to 2016.
Injectable anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of injectable anticoagulants used to treat AF, and the revenue in 2016 is 3400 M USD.
Over the next five years, Study projects that Injectable Anticoagulants will register a 2.7% CAGR in terms of revenue, reach US$ 6440 million by 2023, from US$ 5490 million in 2017.
This report studies the global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 players in each region, with sales, price, revenue and market share from 2013 to 2018, the top players:
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka
Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top players in these regions, from 2013 to 2018 (forecast), like
North America (United States, Canada and Mexico)
Asia-Pacific (China, Japan, Southeast Asia, India and Korea)
Europe (Germany, UK, France, Italy and Russia etc.)
South America (Brazil, Chile, Peru and Argentina)
Middle East and Africa (Egypt, South Africa, Saudi Arabia)
Split by Product Types, with sales, revenue, price, market share of each type, can be divided into
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Other
Split by applications, this report focuses on sales, market share and growth rate in each application, can be divided into
VTE
ACS/MI
AF
Other
Spanning over 125 pages "Forecast of Global Injectable Anticoagulants Players Market 2023" report covers Injectable Anticoagulants Market Overview, Global Injectable Anticoagulants Sales, Revenue (Value) and Market Share by Players, Global Injectable Anticoagulants Sales, Revenue (Value) by Regions, Type and Application (2013-2018), North America Top 5 Players Injectable Anticoagulants Sales, Revenue and Price, Europe Top 5 Players Injectable Anticoagulants Sales, Revenue and Price, Asia-Pacific Top 5 Players Injectable Anticoagulants Sales, Revenue and Price, South America Top 5 Players Injectable Anticoagulants Sales, Revenue and Price, Middle East & Africa Top 5 Players Injectable Anticoagulants Sales, Revenue and Price, Global Injectable Anticoagulants Players Profiles/Analysis, Global Injectable Anticoagulants Market Forecast (2018-2023), Injectable Anticoagulants Manufacturing Cost Analysis, Industrial Chain, Sourcing Strategy and Downstream Buyers, Marketing Strategy Analysis, Distributors/Traders, Market Effect Factors Analysis, Research Findings and Conclusion, Appendix.
Please visit this link for more details: https://www.marketresearchreports.com/mrrpb2/forecast-global-injectable-anticoagulants-players-market-2023
Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare
For related reports please visit: https://www.marketresearchreports.com/search/site/Injectable%2520Anticoagulant
Read our Interactive Market Research Blog
About MarketResearchReprots.com
MarketResearchReprots.com is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.
Contact us for your market research requirements: https://www.marketresearchreports.com/contact
Global Injectable Anticoagulants Market Will Grow at a CAGR 2.7% and Reach USD 6.44 Billion by 2023, from USD 5.49 Billion in 2017
New Global Injectable Anticoagulants Players Market 2023 Report Covers market forecast and top Companies like Sanofi, Genentech (Roche), Boehringer Ingelheim, Pfizer, The Medicines Company and others.